Advertisement

Identification of Efflux-Mediated Multi-drug Resistance in Bacterial Clinical Isolates by Two Simple Methods

  • Marta Martins
  • Isabel Couto
  • Miguel Viveiros
  • Leonard Amaral
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 642)

Abstract

Two simple, instrument-free, user-friendly methods that can readily be implemented by a routine microbiology laboratory are described for the detection of multi-drug-resistant (MDR) isolates that overexpress efflux pump (EP) systems responsible for the MDR phenotype. The first method employs the universal EP substrate ethidium bromide (EB) at varying concentrations in agar-containing plates upon which the contents of an overnight culture are swabbed as spokes of a wheel. In this method, named the EB–agar cartwheel method, it is assumed that the smallest concentration of EB that produces fluorescence of the bacterial mass represents the highest concentration of EB that the bacteria can exclude. Consequently, as the efflux system(s) of a given MDR clinical bacterial isolate is overexpressed relative to that of a reference strain, the minimal concentration of EB producing fluorescence is significantly greater. A simple formula is provided which affords the ranking of MDR clinical isolates with respect to the degree of their efflux capacity. The second method, which can be used after the first one, determines whether the MDR phenotype is based upon an overexpressed efflux system. This method employs a 24-well microplate with separate wells containing or lacking an efflux pump inhibitor (EPI) and Kirby–Bauer discs that correspond to the antibiotics to which the MDR strain is resistant. After the wells are inoculated with the MDR clinical isolate, the plate is incubated overnight and each well is evaluated by eye for evidence of growth. Comparison of growth to the relevant control enables the observer to determine the following outcomes: no growth produced by the EPI–antibiotic combination (i.e., reversal of antibiotic resistance); reduced growth produced by the EPI–antibiotic combination; no difference in growth, i.e., EPI does not affect the resistance to the given antibiotic. If the first method showed that there was a significant difference between the minimum concentrations of EB in agar that produced fluorescence for the clinical isolate and its reference strain, then one can conclude that if the EPI had no effect on reducing antibiotic resistance, the differences in the EB concentrations that produced fluorescence are probably due to differences in the permeability of the strain to EB, reflecting a downregulation of porins if the clinical isolate is a Gram-negative bacterium.

Key words

Multi-drug resistance Efflux pumps Efflux pump inhibitors Ethidium bromide Screening methods 

Notes

Acknowledgments

We thank Seamus Fanning and Jean-Marie Pagès for providing the Salmonella and Enterobacter strains, respectively. The help/participation of Gabriella Spengler, Liliana Rodrigues, Ana Martins, Ana Cardoso, Nadia Charepe, Celeste Falcão, Sofia Santos Costa, and Daniela Sampaio in the characterization of reference and clinical bacterial strains by the methods described is also acknowledged. This work was supported by grants EU-FSE/FEDER-POCI/SAU-MMO/59370/2004 and EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006 provided by the Fundação para a Ciência e a Tecnologia (FCT) of Portugal. M. Martins was supported by grant SFRH/BD/14319/2003 (FCT, Portugal).

References

  1. 1.
    Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656CrossRefPubMedGoogle Scholar
  2. 2.
    Zgurskaya HI, Nikaido H (2000) Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol 37:219–225CrossRefPubMedGoogle Scholar
  3. 3.
    Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M et al (2007) Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2:e365CrossRefPubMedGoogle Scholar
  4. 4.
    Poole K (2007) Efflux pumps as antimicrobial resistance mechanisms. Ann Med 39:162–176CrossRefPubMedGoogle Scholar
  5. 5.
    Van Bambeke F, Pagès JM, Lee VJ (2006) Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents Anti-Infect Drug Disc 1:157–175CrossRefGoogle Scholar
  6. 6.
    Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382–402CrossRefPubMedGoogle Scholar
  7. 7.
    Piddock LJ (2006) Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4:629–636CrossRefPubMedGoogle Scholar
  8. 8.
    Li XZ, Nikaido H (2004) Efflux-mediated drug resistance in bacteria. Drugs 64:159–204CrossRefPubMedGoogle Scholar
  9. 9.
    Li XZ, Zhang L, Nikaido H (2004) Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother 48:2415–2423CrossRefPubMedGoogle Scholar
  10. 10.
    Nikaido H, Zgurskaya HI (1999) Antibiotic efflux mechanisms. Curr Opin Infect Dis 12:529–536PubMedGoogle Scholar
  11. 11.
    Lomovskaya O, Bostian KA (2006) Practical applications and feasibility of efflux pump inhibitors in the clinic–a vision for applied use. Biochem Pharmacol 71:910–918CrossRefPubMedGoogle Scholar
  12. 12.
    Lomovskaya O, Watkins WJ (2001) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699–1711PubMedGoogle Scholar
  13. 13.
    Marquez B (2005) Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87:1137–1147CrossRefPubMedGoogle Scholar
  14. 14.
    Khan SZ, Longland CL, Michelangeli F (2000) The effects of phenothiazines and other calmodulin antagonists on the sarcoplasmic and endoplasmic reticulum Ca(2+) pumps. Biochem Pharmacol 60:1797–1806CrossRefPubMedGoogle Scholar
  15. 15.
    Amaral L, Martins M, Viveiros M (2007) Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59:1237–1246CrossRefPubMedGoogle Scholar
  16. 16.
    Clausen T (2003) Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83:1269–1324PubMedGoogle Scholar
  17. 17.
    Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A 97:1433–1437CrossRefPubMedGoogle Scholar
  18. 18.
    Kaatz GW, Moudgal VV, Seo SM (2002) Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 50:833–838CrossRefPubMedGoogle Scholar
  19. 19.
    Nakajima Y (1999) Mechanisms of bacterial resistance to macrolide antibiotics. J Infect Chemother 5:61–74CrossRefPubMedGoogle Scholar
  20. 20.
    Baquero F (2001) Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 4:93–105CrossRefPubMedGoogle Scholar
  21. 21.
    Joux F, Lebaron P (2000) Use of fluorescent probes to assess physiological functions of bacteria at single-cell level. Microb Infect 2:1523–1535CrossRefGoogle Scholar
  22. 22.
    Jernaes MW, Steen HB (1994) Staining of Escherichia coli for flow cytometry: influx and efflux of Ethidium bromide. Cytometry 17:302–309CrossRefGoogle Scholar
  23. 23.
    Mortimer PG, Piddock LJ (1991) A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28:639–653CrossRefPubMedGoogle Scholar
  24. 24.
    Duffy L, Dykes GA (2006) Growth temperature of four Campylobacter jejuni strains influences their subsequent survival in food and water. Lett Appl Microbiol 43:596–601CrossRefPubMedGoogle Scholar
  25. 25.
    Martins M, Cardoso A, Viveiros M, Amaral L (2007) Simple method to screen inhibitors of bacterial efflux pumps. Abstract C2-2056, p.148. In: Proceedings of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, Chicago, Il, USA.Google Scholar
  26. 26.
    Martins M, Cardoso A, Viveiros M, Charepe N, Rodrigues L, Couto I, et al (2008) Simple methods to screen efflux pump activity and efflux pump inhibitors in multi-drug resistant Escherichia coli. Abstract P1998, p.159. In: Proceedings of the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). European Society of Clinical Microbiology and Infectious Diseases, Barcelona, Spain.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marta Martins
    • 1
  • Isabel Couto
    • 2
    • 3
  • Miguel Viveiros
    • 2
  • Leonard Amaral
    • 1
  1. 1.Unit of Mycobacteriology and UPMM, Instituto de Higiene e Medicina TropicalUniversidade Nova de Lisboa (IHMT/UNL)LisboaPortugal
  2. 2.Unit of Mycobacteriology, Instituto de Higiene e Medicina TropicalUniversidade Nova de Lisboa (IHMT/UNL)LisboaPortugal
  3. 3.Centro de Recursos Microbiológicos (CREM), Faculdade de Ciências e TecnologiaUniversidade Nova de LisboaCaparicaPortugal

Personalised recommendations